Females have a 31% higher associated risk of developing long COVID, with women aged 40 to 55 years having the highest propensity, according to a study led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) funded by the National Institutes of Health.
Codagenix pursues RSV vaccine development amid unexpected challenges – Pharmaceutical Technology
The reason for the trial delay was related to an issue with finding seropositive older toddlers due to the isolation of this age group during